Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure

References

• Ammar KA, Jacobsen SJ, Mahoney DW, et al. (2007). Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 115:1563–70.
   PubMed Web of Science ®Google Scholar
• Arora P, Reingold J, Baggish A, et al. (2015). Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc 4:e001265.
   PubMed Web of Science ®Google Scholar
• Chahal H, Bluemke DA, Wu CO, et al. (2015). Heart failure risk prediction in the multi-ethnic study of atherosclerosis. Heart 101:58–64.
   PubMed Web of Science ®Google Scholar
• Dessi-Fulgheri P, Sarzani R, Tamburrini P, et al. (1997). Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 15:1695–9.
   PubMed Web of Science ®Google Scholar
• Hebert K, Horswell R, Heidenreich P, et al. (2010). Handheld ultrasound, B-natriuretic peptide for screening stage B heart failure. South Med J 103:616–22.
   PubMed Web of Science ®Google Scholar
• Huelsmann M, Neuhold S, Resl M, et al. (2013). PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial. J Am Coll Cardiol 62:1365–72.
   PubMed Web of Science ®Google Scholar
• Ichiki T, Huntley BK, Burnett JC. JR. (2013). BNP molecular forms and processing by the cardiac serine protease corin. Adv Clin Chem 61:1–31.
   PubMed Web of Science ®Google Scholar
• Jan A, Dawkins I, Murphy N, et al. (2013). Associates of an elevated natriuretic peptide level in stable heart failure patients: implications for targeted management. Scientific World J 2013:562763.
   Web of Science ®Google Scholar
• Kannel WB, Hjortland M, Castelli WP. (1974). Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34.
   PubMed Web of Science ®Google Scholar
• Khan AM, Cheng S, Magnusson M, et al. (2011). Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab 96:3242–9.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy P, Lubien E, Clopton P, et al. (2001). Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 111:274–9.
   PubMed Web of Science ®Google Scholar
• Ledwidge M, Gallagher J, Conlon C, et al. (2013). Natriuretic peptide-based screening and collaborative care for heart failure: the stop-Hf randomized trial. JAMA 310:66–74.
   PubMed Web of Science ®Google Scholar
• Lubien E, Demaria A, Krishnaswamy P, et al. (2002). Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595–601.
   PubMed Web of Science ®Google Scholar
• Maisel AS, Koon J, Krishnaswamy P, et al. (2001). Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141:367–74.
   PubMed Web of Science ®Google Scholar
• Murtagh G, Dawkins IR, O’Connell R, et al. (2012). Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction. Eur J Heart Fail 14:480–6.
   PubMed Web of Science ®Google Scholar
• Nadir MA, Gandy S, Ireland S, et al. (2015). An increased B-type natriuretic peptide in the absence of a cardiac abnormality identifies those whose left ventricular mass will increase over time. JACC Heart Fail 3:87–93.
   PubMed Web of Science ®Google Scholar
• Peng J, Jiang J, Wang W, et al. (2011). Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes. Biochem Biophys Res Commun 411:593–8.
   PubMed Web of Science ®Google Scholar
• Pivovarova O, Gögebakan Ö, Klöting N, et al. (2012). Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab 97:E731–9.
   PubMed Web of Science ®Google Scholar
• Rathi S, Deedwania PC. (2012). The epidemiology and pathophysiology of heart failure. Med Clin North Am 96:881–90.
   PubMed Web of Science ®Google Scholar
• Ravida A, Musante L, Kreivi M, et al. (2015). Glycosylation patterns of kidney proteins differ in rat diabetic nephropathy. Kidney Int 87:963–74.
   PubMed Web of Science ®Google Scholar
• Semenov AG, Postnikov AB, Tamm NN, et al. (2009). Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem 55:489–98.
   PubMed Web of Science ®Google Scholar
• Semenov AG, Tamm NN, Seferian KR, et al. (2010). Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin Chem 56:1166–76.
   PubMed Web of Science ®Google Scholar
• Sugisawa T, Kishimoto I, Kokubo Y, et al. (2010). Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes. Diabetes Res Clin Pract 89:174–80.
   PubMed Web of Science ®Google Scholar
• Testa R, Vanhooren V, Bonfigli AR, et al. (2015). N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters. PLoS One 10:e0119983.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Benjamin EJ, Larson MG, et al. (2002). Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288:1252–9.
   PubMed Web of Science ®Google Scholar
• Vodovar N, Seronde MF, Laribi S, et al. (2014). Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. Eur Heart J 35:3434–41.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. (2004). Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594–600.
   PubMed Web of Science ®Google Scholar